Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 Cases (1996-2002)

Journal of the American Veterinary Medical Association

Volumn 228, Issue 7, 2006, Pages 1053-1062

  Ettinger, Susan N ^a,b   Scase, Timothy J ^a,c   Oberthaler, Karen T ^a,d   Craft, Diane M ^a   McKnight, Josephine A ^a   Leibman, Nicole F ^a   Charney, Sarah C ^a,e   Bergman, Philip J ^a  

^a ANIMAL MEDICAL CENTER   (United States)

^b South Bay Veterinary Specialists   (United States)

^c ANIMAL HEALTH TRUST   (United Kingdom)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Southwest Veterinary Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ANIMAL TISSUE; ARGYROPHILIA; CANCER GRADING; CHROMOSOME NOR; DOG; FEMALE; FOLLOW UP; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MITOSIS INDEX; MULTIVARIATE ANALYSIS; NONHUMAN; PATIENT MONITORING; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SOFT TISSUE SARCOMA; SURVIVAL RATE; SURVIVAL TIME;

ANIMALIA; CANIS FAMILIARIS;

EID: 33645462971     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.228.7.1053     Document Type: Review

References (25)

1. MacEwen E, Powers B, Macy D. Soft tissue sarcomas. In: Withrow SJ, MacEwan EG, eds. Small animal clinical oncology. 3rd ed. New York: WB Saunders Co, 2001;283-304.
2. Mauldin GN. Soft tissue sarcomas. Vet Clin North Am Small Anim Pract 1997;27:139-148.
3. Bostock DE, Dye MT. Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol 1980;17:581-588.
4. Kuntz CA, Dernell WS, Powers BE, et al. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc 1997;211:1147-1151.
5. Pfeifer JD, Hill DA, O'Sullivan MJ, et al. Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology 2000;37:485-500.
6. Brennan M, Alektiar K, Maki R. Sarcomas of the soft tissue and bone. In: DeVita VT, Hill DA, Rosenberg SA, eds. Cancer principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001;1841-1935.
7. Oliveira AM, Nascimento AG. Grading in soft tissue tumors: principles and problems. Skeletal Radiol 2001;30:543-559.
8. van Unnik JA, Coindre JM, Contesso C, et al. Grading of soft tissue sarcomas: experience of the European Organisation for Research and Treatment of Cancer (EORTC). Soft Tissue and Bone Sarcoma Group. Eur J Cancer 1993;29A:2089-2093.
9. Costa J, Wesley RA, Glatstein E, et al. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984;53:530-541.
10. Markhede G, Angervall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 1982;49:1721-1733.
11. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42.
12. Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58:306-309.
13. Abadie JJ, Amardeilh MA, Delverdier ME. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999;215:1629-1634.
14. Madewell BR. Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications. J Vet Intern Med 2001;15:334-340.
15. Arora HL, Arora N, Solanki RL. Argyrophilic nucleolar organizer regions in soft tissue tumors. Indian J Pathol Microbiol 1996;39:257-263.
16. Kuratsu S, Myoui A, Tomita Y, et al. Usefulness of argyrophilic nucleolar organizer staining for histologic grading of soft-tissue sarcomas. J Surg Oncol 1993;54:139-145.
17. Kuratsu S, Ohsawa M, Naka N, et al. Usefulness of argyrophilic nucleolar organizer staining for predicting prognosis of patients with recurrent soft tissue sarcoma. Oncology 1994;51:244-250.
18. Drobnjak M, Latres E, Pollack D, et al. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst 1994;86:549-554.
19. Vail DM, Kisseberth WC, Obradovich JE, et al. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Exp Hematol 1986;14:807-815.
20. McKnight JA, Mauldin GN, McEntee MC, et al. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs. J Am Vet Med Assoc 2000;217:205-210.
21. Forrest LJ, Chun R, Adams WM, et al. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 2000;14:578-582.
22. Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 2003;237:218-226.
23. Ferguson PC, Deshmukh N, Abudu A, et al. Change in histologic grade in locally recurrent soft tissue sarcomas. Eur J Cancer 2004;40:2237-2242.
24. Langenbach A, McManus PM, Hendrick MJ, et al. Sensitivity and specificity of methods of assessing the regional lymph nodes for evidence of metastasis in dogs and cats with solid tumors. J Am Vet Med Assoc 2001;218:1424-1428.
25. Williams LE, Packer RA. Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987-2001). J Am Vet Med Assoc 2003;222:1234-1236.